Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis (vol 90, 107187, 2021)

被引：1
|
作者：
Wu, Ya-xian [1 ,4 ]
Zeng, Si [2 ]
Wan, Bin-bin [1 ]
Wang, Ying-ying [1 ]
Sun, Hong-xu [3 ]
Liu, Gang [1 ]
Gao, Zhi-qi [1 ]
Chen, Dan [1 ]
Chen, Yong-quan [1 ,4 ]
Lu, Mu-dan [5 ]
Pang, Qing-feng [1 ]
机构：
[1] Jiangnan Univ, Wuxi Sch Med, Wuxi, Jiangsu, Peoples R China
[2] Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China
[3] Hosp Jiangnan Univ, Wuxi, Jiangsu, Peoples R China
[4] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Jiangsu, Peoples R China
[5] Nanjing Med Univ, Affiliated Wuxi Matem & Child Hlth Care Hosp, Cent Lab, Wuxi, Jiangsu, Peoples R China
来源：
INTERNATIONAL IMMUNOPHARMACOLOGY | 2023年 / 124卷
关键词：
D O I：
10.1016/j.intimp.2023.111008
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis
    Wu, Ya-Xian
    Zeng, Si
    Wan, Bin-Bin
    Wang, Ying-Ying
    Sun, Hong-Xu
    Liu, Gang
    Gao, Zhi-Qi
    Chen, Dan
    Chen, Yong-Quan
    Lu, Mu-Dan
    Pang, Qing-Feng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 90
  • [2] Ethyl ferulate protects against lipopolysaccharide-induced acute lung injury by activating AMPK/Nrf2 signaling pathway
    Wu, Ya-xian
    Wang, Ying-ying
    Gao, Zhi-qi
    Chen, Dan
    Liu, Gang
    Wan, Bin-bin
    Jiang, Feng-juan
    Wei, Ming-xia
    Zuo, Jing
    Zhu, Jun
    Chen, Yong-quan
    Qian, Feng
    Pang, Qing-feng
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (12) : 2069 - 2081
  • [3] Ethyl ferulate protects against lipopolysaccharide-induced acute lung injury by activating AMPK/Nrf2 signaling pathway
    Ya-xian Wu
    Ying-ying Wang
    Zhi-qi Gao
    Dan Chen
    Gang Liu
    Bin-bin Wan
    Feng-juan Jiang
    Ming-xia Wei
    Jing Zuo
    Jun Zhu
    Yong-quan Chen
    Feng Qian
    Qing-feng Pang
    Acta Pharmacologica Sinica, 2021, 42 : 2069 - 2081
  • [4] Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway
    Lu, Ying
    Yu, Ting
    Liu, Jingyao
    Gu, Lina
    PLOS ONE, 2018, 13 (04):
  • [5] Azilsartan attenuates lipopolysaccharide-induced acute lung injury via the Nrf2/HO-1 signaling pathway
    Chengshi Zhang
    Yunfeng Zhao
    Xiaorong Yang
    Immunologic Research, 2022, 70 : 97 - 105
  • [6] Azilsartan attenuates lipopolysaccharide-induced acute lung injury via the Nrf2/HO-1 signaling pathway
    Zhang, Chengshi
    Zhao, Yunfeng
    Yang, Xiaorong
    IMMUNOLOGIC RESEARCH, 2022, 70 (01) : 97 - 105
  • [7] Glycine Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Regulating NLRP3 Inflammasome and NRF2 Signaling
    Zhang, Yunchang
    Ma, Xiaoshi
    Ma, Jiang
    Chen, Jingqing
    Jia, Hai
    Wu, Zhenlong
    Kim, In Ho
    Yang, Ying
    NUTRIENTS, 2020, 12 (03)
  • [8] Isorhapontigenin alleviates lipopolysaccharide-induced acute lung injury via modulating Nrf2 signaling
    Yao, Peiyu
    Zhang, Zhuo
    Cao, Jie
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2021, 289
  • [9] Dimethyl fumarate attenuates lipopolysaccharide-induced mitochondrial injury by activating Nrf2 pathway in cardiomyocytes
    Fu, Chun-Yan
    Chen, Jun
    Lu, Xiao-Yang
    Zheng, Ming-Zhi
    Wang, Lin-Lin
    Shen, Yue-Liang
    Chen, Ying-Ying
    LIFE SCIENCES, 2019, 235
  • [10] Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway
    Pan, Chen-wei
    Yang, Shou-xing
    Pan, Zhen-zhen
    Zheng, Bo
    Wang, Jian-zhang
    Lu, Guang-rong
    Xue, Zhan-xiong
    Xu, Chang-long
    ONCOTARGET, 2017, 8 (25) : 41202 - 41210
12345